Health In Tech Appoints Zain Hasan as Chief Growth Officer
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 13 2026
0mins
Health In Tech announced that its Board of Directors has appointed Zain Hasan as Chief Growth Officer. Hasan joined Health In Tech in September 2025 and has played a key role in advancing the Company's go-to-market execution, distribution expansion, and enterprise growth initiatives. In his new role as Chief Growth Officer, Hasan will lead Health In Tech's company-wide growth strategy, with responsibility for revenue generation and performance across sales, distributions, partnerships, and revenue operations. With more than 15 years of experience in the employee benefits and insurance industry, Hasan is a five-time founder and former CEO who has successfully built and exited multiple companies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HIT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HIT
Wall Street analysts forecast HIT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.010
Low
4.50
Averages
4.50
High
4.50
Current: 1.010
Low
4.50
Averages
4.50
High
4.50
About HIT
Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Health In Tech Q1 2026 Earnings Call Insights
- Strategic Investment Plan: Health In Tech plans to strategically invest in 2026, with CEO Tim Johnson stating that approximately $7 million from a PIPE financing will be used to expand the sales distribution network and enhance technology architecture, aiming to increase market share and drive long-term revenue growth.
- Revenue and Growth Outlook: The total revenue for Q1 2026 was reported at $8.8 million, reflecting a year-over-year growth of about 9%, with the company projecting full-year revenue between $45 million and $50 million, indicating a potential growth rate of 35% to 50%.
- Introduction of New KPIs: CFO Julia Qian mentioned the introduction of new key performance indicators, including $22.9 million in contracted revenue and $82 million in platform placed plan value, aimed at enhancing financial transparency and supporting future business expansion.
- Profitability Challenges: Despite revenue growth, the adjusted EBITDA for Q1 was negative $1.3 million, with a net loss of $1.6 million, primarily due to increased investments in sales, marketing, and product development, highlighting the profitability pressures faced during the expansion phase.
See More
Health In Tech Reports Q1 Earnings with Revenue Beat and Guidance for 2026
- Earnings Performance: Health In Tech, Inc. reported a Q1 GAAP EPS of -$0.03, missing expectations by $0.01, while revenue reached $8.8 million, reflecting a 9.9% year-over-year increase and beating estimates by $1.34 million, indicating resilience in revenue growth.
- Adjusted EBITDA: The adjusted EBITDA for Q1 totaled -$1.3 million, down from $1.2 million in Q1 2025, primarily due to increased sales and marketing expenses, which reflect the company's strategic investments aimed at driving long-term revenue growth.
- Working Capital Status: As of March 31, 2026, the company's working capital stood at $15 million, significantly up from $8.8 million as of March 31, 2025, indicating improved financial health and providing stronger support for future growth.
- 2026 Revenue Guidance: Health In Tech reiterated its revenue guidance for 2026, projecting between $45 million and $50 million, representing a year-over-year growth of approximately 35% to 50%, with contracted revenue of $22.9 million for the remaining three quarters, providing good visibility into full-year revenue.
See More
Health In Tech to Present at Market Movers Investor Summit
- Investor Summit Participation: Health In Tech will present its AI-driven InsurTech platform at the Market Movers Investor Summit on May 5, 2026, at the historic Bank of New York, which is expected to draw significant investor interest.
- High-Caliber Event Schedule: The summit kicks off on May 4 and includes company presentations, keynote sessions, and one-on-one meetings, aimed at providing a premium networking experience for public and private company executives and investors, enhancing the company's visibility.
- Showcasing Industry Innovation: Health In Tech's platform simplifies health insurance processes and offers a self-service health insurance marketplace, helping insurers and brokers improve efficiency, which is likely to attract more clients and partners.
- Market Potential: As the demand for automation and streamlined processes in the health insurance sector grows, Health In Tech's innovative solutions are poised to significantly increase market share and revenue in the coming years.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.
See More
Health In Tech Q1 2026 Earnings Call Insights
- Strategic Investment Plan: Health In Tech plans to strategically invest in 2026, with CEO Tim Johnson stating that approximately $7 million from a PIPE financing will be used to expand the sales distribution network and enhance technology architecture, aiming to increase market share and drive long-term revenue growth.
- Revenue and Growth Outlook: The total revenue for Q1 2026 was reported at $8.8 million, reflecting a year-over-year growth of about 9%, with the company projecting full-year revenue between $45 million and $50 million, indicating a potential growth rate of 35% to 50%.
- Introduction of New KPIs: CFO Julia Qian mentioned the introduction of new key performance indicators, including $22.9 million in contracted revenue and $82 million in platform placed plan value, aimed at enhancing financial transparency and supporting future business expansion.
- Profitability Challenges: Despite revenue growth, the adjusted EBITDA for Q1 was negative $1.3 million, with a net loss of $1.6 million, primarily due to increased investments in sales, marketing, and product development, highlighting the profitability pressures faced during the expansion phase.
See More
Health In Tech Reports Q1 Earnings with Revenue Beat and Guidance for 2026
- Earnings Performance: Health In Tech, Inc. reported a Q1 GAAP EPS of -$0.03, missing expectations by $0.01, while revenue reached $8.8 million, reflecting a 9.9% year-over-year increase and beating estimates by $1.34 million, indicating resilience in revenue growth.
- Adjusted EBITDA: The adjusted EBITDA for Q1 totaled -$1.3 million, down from $1.2 million in Q1 2025, primarily due to increased sales and marketing expenses, which reflect the company's strategic investments aimed at driving long-term revenue growth.
- Working Capital Status: As of March 31, 2026, the company's working capital stood at $15 million, significantly up from $8.8 million as of March 31, 2025, indicating improved financial health and providing stronger support for future growth.
- 2026 Revenue Guidance: Health In Tech reiterated its revenue guidance for 2026, projecting between $45 million and $50 million, representing a year-over-year growth of approximately 35% to 50%, with contracted revenue of $22.9 million for the remaining three quarters, providing good visibility into full-year revenue.
See More
Health In Tech to Present at Market Movers Investor Summit
- Investor Summit Participation: Health In Tech will present its AI-driven InsurTech platform at the Market Movers Investor Summit on May 5, 2026, at the historic Bank of New York, which is expected to draw significant investor interest.
- High-Caliber Event Schedule: The summit kicks off on May 4 and includes company presentations, keynote sessions, and one-on-one meetings, aimed at providing a premium networking experience for public and private company executives and investors, enhancing the company's visibility.
- Showcasing Industry Innovation: Health In Tech's platform simplifies health insurance processes and offers a self-service health insurance marketplace, helping insurers and brokers improve efficiency, which is likely to attract more clients and partners.
- Market Potential: As the demand for automation and streamlined processes in the health insurance sector grows, Health In Tech's innovative solutions are poised to significantly increase market share and revenue in the coming years.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.
See More
